TuHURA BIOSCIENCES, INC./NV Gain (Loss) on Derivative Instruments, Net, Pretax
TuHURA BIOSCIENCES, INC./NV (HURA) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$433.50 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2020-09-18.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2020-09-18
- TuHURA BIOSCIENCES, INC./NV gain (loss) on derivative instruments, net, pretax for the quarter ending 2019-06-30 was -$434.36K.
- TuHURA BIOSCIENCES, INC./NV gain (loss) on derivative instruments, net, pretax for the quarter ending 2019-03-31 was -$189.00, a 108.75% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-12-31 was $1.26K.
- TuHURA BIOSCIENCES, INC./NV gain (loss) on derivative instruments, net, pretax for the quarter ending 2018-09-30 was -$220.00, a 100.39% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV gain (loss) on derivative instruments, net, pretax for fiscal 2019 was -$433.50K.
- TuHURA BIOSCIENCES, INC./NV gain (loss) on derivative instruments, net, pretax for fiscal 2018 was -$60.11K.
- TuHURA BIOSCIENCES, INC./NV gain (loss) on derivative instruments, net, pretax for fiscal 2016 was $2.34M, a 273.21% increase from fiscal 2015.
- TuHURA BIOSCIENCES, INC./NV gain (loss) on derivative instruments, net, pretax for fiscal 2015 was $627.43K.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 1 month | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month as first filed | Gain (Loss) on Derivative Instruments, Net, Pretax 14 month | Gain (Loss) on Derivative Instruments, Net, Pretax 36 month | Gain (Loss) on Derivative Instruments, Net, Pretax 42 month | Gain (Loss) on Derivative Instruments, Net, Pretax 45 month | Gain (Loss) on Derivative Instruments, Net, Pretax 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$434.36K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | -$434.54K derived: sum of 2 quarters · filed 2020-09-18 | -$433.28K derived: sum of 3 quarters · filed 2020-09-18 | -$433.50K 10-K · filed 2020-09-18 | ||||||||||
| 2019-03-31 | -$189.00 10-Q · filed 2020-05-13 | $1.07K derived: sum of 2 quarters · filed 2020-05-13 | $852.00 10-Q · filed 2020-05-13 | -$117.10K derived: sum of 4 quarters · filed 2020-05-13 | ||||||||||
| 2018-12-31 | $1.26K 10-Q · filed 2020-02-13 | $1.04K 10-Q · filed 2020-02-13 | -$116.91K derived: sum of 3 quarters · filed 2020-02-13 | -$114.75K derived: sum of 4 quarters · filed 2020-02-13 | ||||||||||
| 2018-09-30 | -$220.00 10-Q · filed 2019-11-13 | -$118.17K derived: sum of 2 quarters · filed 2019-11-13 | -$116.01K derived: sum of 3 quarters · filed 2019-11-13 | -$116.90K derived: sum of 4 quarters · filed 2019-11-13 | ||||||||||
| 2018-06-30 | -$117.95K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09 | -$115.79K derived: sum of 2 quarters · filed 2019-09-09 | -$116.68K derived: sum of 3 quarters · filed 2019-09-09 | -$60.11K 10-K · filed 2019-09-09 | ||||||||||
| 2018-03-31 | $2.16K 10-Q · filed 2019-05-14 | $1.27K derived: sum of 2 quarters · filed 2019-05-14 | $57.84K 10-Q · filed 2019-05-14 | $245.30K derived: sum of 4 quarters · filed 2019-06-03 | ||||||||||
| 2017-12-31 | -$889.00 10-Q · filed 2019-02-11 | $55.68K 10-Q · filed 2019-02-11 | $243.14K derived: sum of 3 quarters · filed 2019-06-03 | $165.66K derived: sum of 4 quarters · filed 2019-06-03 | ||||||||||
| 2017-09-30 | $56.57K 10-Q · filed 2018-11-13 | $244.03K derived: sum of 2 quarters · filed 2019-06-03 | $166.55K derived: sum of 3 quarters · filed 2019-06-03 | $528.22K derived: sum of 4 quarters · filed 2019-06-03 | ||||||||||
| 2017-06-30 | $187.46K derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | $109.98K derived: sum of 2 quarters · filed 2019-06-03 | $471.65K derived: sum of 3 quarters · filed 2019-06-03 | $245.96K 8-K · filed 2019-06-03 | -$245.96K 10-K · filed 2017-09-27 | |||||||||
| 2017-03-31 | -$77.48K 10-Q · filed 2018-05-15 | $77.48K 10-Q · filed 2017-05-12 | $284.19K derived: sum of 2 quarters · filed 2018-05-15 | $58.50K 10-Q · filed 2018-05-15 | -$58.50K 10-Q · filed 2017-05-12 | $1.46M derived: sum of 4 quarters · filed 2018-05-15 | ||||||||
| 2016-12-31 | $361.67K 10-Q · filed 2018-02-14 | -$361.67K 10-Q · filed 2017-02-10 | $135.98K 10-Q · filed 2018-02-14 | -$135.98K 10-Q · filed 2017-02-10 | $1.53M derived: sum of 3 quarters · filed 2018-02-14 | $1.26M derived: sum of 4 quarters · filed 2018-02-14 | ||||||||
| 2016-09-30 | -$225.69K 10-Q · filed 2017-11-09 | $1.17M derived: sum of 2 quarters · filed 2017-11-09 | $896.34K derived: sum of 3 quarters · filed 2017-11-09 | $1.58M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||
| 2016-06-30 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | $1.12M derived: sum of 2 quarters · filed 2017-09-27 | $1.80M derived: sum of 3 quarters · filed 2017-09-27 | $2.34M 10-K · filed 2017-09-27 | -$2.34M 10-K · filed 2016-09-13 | |||||||||
| 2016-03-31 | -$276.58K 10-Q · filed 2017-05-12 | $276.58K 10-Q · filed 2016-05-12 | $403.60K derived: sum of 2 quarters · filed 2017-05-12 | $943.05K 10-Q · filed 2017-05-12 | -$943.05K 10-Q · filed 2016-05-12 | $943.38K derived: sum of 4 quarters · filed 2017-05-12 | ||||||||
| 2015-12-31 | $680.19K 10-Q · filed 2017-02-10 | -$680.19K 10-Q · filed 2016-02-12 | $1.22M 10-Q · filed 2017-02-10 | -$1.22M 10-Q · filed 2016-02-12 | $1.22M derived: sum of 3 quarters · filed 2017-02-10 | $438.82K derived: sum of 4 quarters · filed 2017-02-10 | ||||||||
| 2015-09-30 | -$539.45K 10-Q · filed 2016-11-10 | $539.45K 10-Q · filed 2015-11-16 | $539.78K derived: sum of 2 quarters · filed 2016-11-10 | -$241.37K derived: sum of 3 quarters · filed 2016-11-10 | $650.96K derived: sum of 4 quarters · filed 2016-11-10 | |||||||||
| 2015-06-30 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $298.07K derived: sum of 2 quarters · filed 2016-09-13 | $1.19M derived: sum of 3 quarters · filed 2016-09-13 | $627.43K 10-K · filed 2016-09-13 | -$179.17K 10-K · filed 2015-09-03 | |||||||||
| 2015-03-31 | -$781.15K 10-Q · filed 2016-05-12 | $343.57K 10-Q · filed 2015-05-15 | $111.17K derived: sum of 2 quarters · filed 2016-05-12 | -$451.79K 10-Q · filed 2016-05-12 | $276.96K 10-Q · filed 2015-05-15 | -$1.09M derived: sum of 4 quarters · filed 2016-05-12 | ||||||||
| 2014-12-31 | $892.33K 10-Q · filed 2016-02-12 | -$435.20K 10-Q · filed 2015-02-12 | $329.36K 10-Q · filed 2016-02-12 | -$66.61K 10-Q · filed 2015-02-12 | -$310.44K derived: sum of 3 quarters · filed 2016-02-12 | $1.29M derived: sum of 4 quarters · filed 2016-02-12 | ||||||||
| 2014-09-30 | $562.97K 10-Q · filed 2015-11-16 | $368.59K 10-Q · filed 2014-11-07 | -$1.20M derived: sum of 2 quarters · filed 2015-11-16 | $396.58K derived: sum of 3 quarters · filed 2015-11-16 | $24.09K derived: sum of 4 quarters · filed 2015-11-16 | |||||||||
| 2014-06-30 | $166.39K 10-Q · filed 2015-05-15 | -$1.77M derived: 10-K 6 month − 10-Q 3 month · filed 2014-08-28 | -$166.39K 10-K · filed 2014-08-28 | -$538.88K derived: sum of 3 quarters · filed 2015-05-15 | -$11.53M 10-K · filed 2015-11-16 | $166.39K 10-Q · filed 2014-11-07 | ||||||||
| 2014-03-31 | $1.60M 10-Q · filed 2015-05-15 | -$1.60M 10-Q · filed 2014-05-15 | $1.23M derived: sum of 2 quarters · filed 2015-05-15 | -$6.87M 10-Q · filed 2015-05-15 | -$11.47M derived: sum of 4 quarters · filed 2015-05-15 | $43.20K 10-Q · filed 2014-05-15 | ||||||||
| 2013-12-31 | -$372.49K 10-Q · filed 2015-02-12 | -$8.47M 10-Q · filed 2015-02-12 | -$13.07M derived: sum of 3 quarters · filed 2015-02-12 | $1.32M 10-K · filed 2014-08-28 | $1.64M 10-K · filed 2014-03-10 | |||||||||
| 2013-09-30 | -$8.09M 10-Q · filed 2014-11-07 | $8.09M 10-Q · filed 2013-11-08 | -$12.69M derived: sum of 2 quarters · filed 2014-11-07 | $951.56K 10-Q · filed 2013-11-08 | $1.27M 10-Q · filed 2013-11-08 | |||||||||
| 2013-06-30 | -$4.60M 10-Q · filed 2013-08-12 | -$7.14M 10-K · filed 2014-08-28 | -$6.82M 10-Q · filed 2013-08-12 | |||||||||||
| 2013-03-31 | -$2.54M 10-Q · filed 2014-05-15 | -$2.23M 10-Q · filed 2013-05-15 | ||||||||||||
| 2012-12-31 | $318.50K 10-K · filed 2014-08-28 | |||||||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |